Cargando…

Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases

PURPOSE: Glioblastomas (GB) and solitary brain metastases (BM) are the most common brain tumors in adults. GB and BM may appear similar in conventional magnetic resonance imaging (cMRI). Their management strategies, however, are quite different with significant consequences on clinical outcome. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Heynold, Elisabeth, Zimmermann, Max, Hore, Nirjhar, Buchfelder, Michael, Doerfler, Arnd, Stadlbauer, Andreas, Kremenevski, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410731/
https://www.ncbi.nlm.nih.gov/pubmed/33891264
http://dx.doi.org/10.1007/s11307-021-01604-1
_version_ 1783747161827049472
author Heynold, Elisabeth
Zimmermann, Max
Hore, Nirjhar
Buchfelder, Michael
Doerfler, Arnd
Stadlbauer, Andreas
Kremenevski, Natalia
author_facet Heynold, Elisabeth
Zimmermann, Max
Hore, Nirjhar
Buchfelder, Michael
Doerfler, Arnd
Stadlbauer, Andreas
Kremenevski, Natalia
author_sort Heynold, Elisabeth
collection PubMed
description PURPOSE: Glioblastomas (GB) and solitary brain metastases (BM) are the most common brain tumors in adults. GB and BM may appear similar in conventional magnetic resonance imaging (cMRI). Their management strategies, however, are quite different with significant consequences on clinical outcome. The aim of this study was to evaluate the usefulness of a previously presented physiological MRI approach scoping to obtain quantitative information about microvascular architecture and perfusion, neovascularization activity, and oxygen metabolism to differentiate GB from BM. PROCEDURES: Thirty-three consecutive patients with newly diagnosed, untreated, and histopathologically confirmed GB or BM were preoperatively examined with our physiological MRI approach as part of the cMRI protocol. RESULTS: Physiological MRI biomarker maps revealed several significant differences in the pathophysiology of GB and BM: Central necrosis was more hypoxic in GB than in BM (30 %; P = 0.036), which was associated with higher neovascularization activity (65 %; P = 0.043) and metabolic rate of oxygen (48 %; P = 0.004) in the adjacent contrast-enhancing viable tumor parts of GB. In peritumoral edema, GB infiltration caused neovascularization activity (93 %; P = 0.018) and higher microvascular perfusion (30 %; P = 0.022) associated with higher tissue oxygen tension (33 %; P = 0.020) and lower oxygen extraction from vasculature (32 %; P = 0.040). CONCLUSION: Our physiological MRI approach, which requires only 7 min of extra data acquisition time, might be helpful to noninvasively distinguish GB and BM based on pathophysiological differences. However, further studies including more patients are required. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11307-021-01604-1.
format Online
Article
Text
id pubmed-8410731
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84107312021-09-22 Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases Heynold, Elisabeth Zimmermann, Max Hore, Nirjhar Buchfelder, Michael Doerfler, Arnd Stadlbauer, Andreas Kremenevski, Natalia Mol Imaging Biol Research Article PURPOSE: Glioblastomas (GB) and solitary brain metastases (BM) are the most common brain tumors in adults. GB and BM may appear similar in conventional magnetic resonance imaging (cMRI). Their management strategies, however, are quite different with significant consequences on clinical outcome. The aim of this study was to evaluate the usefulness of a previously presented physiological MRI approach scoping to obtain quantitative information about microvascular architecture and perfusion, neovascularization activity, and oxygen metabolism to differentiate GB from BM. PROCEDURES: Thirty-three consecutive patients with newly diagnosed, untreated, and histopathologically confirmed GB or BM were preoperatively examined with our physiological MRI approach as part of the cMRI protocol. RESULTS: Physiological MRI biomarker maps revealed several significant differences in the pathophysiology of GB and BM: Central necrosis was more hypoxic in GB than in BM (30 %; P = 0.036), which was associated with higher neovascularization activity (65 %; P = 0.043) and metabolic rate of oxygen (48 %; P = 0.004) in the adjacent contrast-enhancing viable tumor parts of GB. In peritumoral edema, GB infiltration caused neovascularization activity (93 %; P = 0.018) and higher microvascular perfusion (30 %; P = 0.022) associated with higher tissue oxygen tension (33 %; P = 0.020) and lower oxygen extraction from vasculature (32 %; P = 0.040). CONCLUSION: Our physiological MRI approach, which requires only 7 min of extra data acquisition time, might be helpful to noninvasively distinguish GB and BM based on pathophysiological differences. However, further studies including more patients are required. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11307-021-01604-1. Springer International Publishing 2021-04-23 2021 /pmc/articles/PMC8410731/ /pubmed/33891264 http://dx.doi.org/10.1007/s11307-021-01604-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Heynold, Elisabeth
Zimmermann, Max
Hore, Nirjhar
Buchfelder, Michael
Doerfler, Arnd
Stadlbauer, Andreas
Kremenevski, Natalia
Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases
title Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases
title_full Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases
title_fullStr Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases
title_full_unstemmed Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases
title_short Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases
title_sort physiological mri biomarkers in the differentiation between glioblastomas and solitary brain metastases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410731/
https://www.ncbi.nlm.nih.gov/pubmed/33891264
http://dx.doi.org/10.1007/s11307-021-01604-1
work_keys_str_mv AT heynoldelisabeth physiologicalmribiomarkersinthedifferentiationbetweenglioblastomasandsolitarybrainmetastases
AT zimmermannmax physiologicalmribiomarkersinthedifferentiationbetweenglioblastomasandsolitarybrainmetastases
AT horenirjhar physiologicalmribiomarkersinthedifferentiationbetweenglioblastomasandsolitarybrainmetastases
AT buchfeldermichael physiologicalmribiomarkersinthedifferentiationbetweenglioblastomasandsolitarybrainmetastases
AT doerflerarnd physiologicalmribiomarkersinthedifferentiationbetweenglioblastomasandsolitarybrainmetastases
AT stadlbauerandreas physiologicalmribiomarkersinthedifferentiationbetweenglioblastomasandsolitarybrainmetastases
AT kremenevskinatalia physiologicalmribiomarkersinthedifferentiationbetweenglioblastomasandsolitarybrainmetastases